Cargando…
Is Treatment for Cytopenic Myelofibrosis Still an Unmet Clinical Need?
Autores principales: | Caduc, Madeline J., Koschmieder, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621927/ https://www.ncbi.nlm.nih.gov/pubmed/37928624 http://dx.doi.org/10.1097/HS9.0000000000000982 |
Ejemplares similares
-
Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib
por: Yacoub, Abdulraheem, et al.
Publicado: (2023) -
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis
por: Coltro, Giacomo, et al.
Publicado: (2022) -
Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
por: Castaman, Giancarlo, et al.
Publicado: (2023) -
Heart Failure with Preserved Ejection Fraction Is a Still Big Unmet Need in Cardiology
por: Ohte, Nobuyuki
Publicado: (2021) -
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs
por: Gremese, Elisa, et al.
Publicado: (2018)